Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/17974
Title: BCG + Mitomycin trial for high-risk non-muscle-invasive bladder cancer: progress report and lessons learned.
Austin Authors: Hayne, Dickon;Stockler, Martin;McCombie, Steve P;Lawrence, Nicola;Martin, Andrew;Sengupta, Shomik ;Davis, Ian D
Affiliation: Australian and New Zealand Urogenital and Prostate Cancer Trials Group (ANZUP), Camperdown, NSW, Australia
University of Western Australia Medical School, Crawley, WA, Australia
Fiona Stanley Hospital Urology, Murdoch, WA, Australia
NHMRC Clinical Trials Centre, University of Sydney, Sydney, NSW, Australia
Department of Urology, Austin Health, Heidelberg, Victoria, Australia
Department of Surgery, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia
Ludwig Institute for Cancer Research, Austin Health, Heidelberg, Victoria, Australia
Monash University Eastern Health Clinical School, Box Hill, Victoria, Australia
Issue Date: May-2017
Publication information: BJU International 2017; 119 (Suppl 5): 55-57
URI: http://ahro.austin.org.au/austinjspui/handle/1/17974
DOI: 10.1111/bju.13873
ORCID: 0000-0002-3920-994X
0000-0003-3357-1216
PubMed URL: 28391606
Type: Journal Article
Appears in Collections:Journal articles

Show full item record

Page view(s)

8
checked on Dec 6, 2022

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.